Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
GT Biopharma, Inc. (GTBP) had Return on Investments of -103.80% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-3.26M |
|
-- |
|
-- |
|
$3.38M |
|
$-3.38M |
|
$0.27M |
|
$-3.11M |
|
$-3.11M |
|
$-3.11M |
|
$-3.11M |
|
$-3.11M |
|
$-3.11M |
|
$-3.38M |
|
$-3.38M |
|
3.94M |
|
3.94M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$3.56M |
|
-- |
|
$0.76M |
|
$4.32M |
|
$1.32M |
|
-- |
|
-- |
|
$1.32M |
|
$3.00M |
|
$3.00M |
|
$3.00M |
|
6.05M |
|
| Cash Flow Statement Financials | |
$-8.89M |
|
-- |
|
$7.47M |
|
$4.04M |
|
$2.62M |
|
$-1.42M |
|
$0.39M |
|
-- |
|
$-0.09M |
|
| Fundamental Metrics & Ratios | |
2.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-103.84% |
|
-103.80% |
|
-72.07% |
|
|
Return on Investments |
-103.80% |
$0.50 |
|
$-2.26 |
|
$-2.26 |
|